Xtant Medical Holdings, Inc. (XTNT)Healthcare | Medical Devices | Belgrade, United States | NYSE American
0.48 USD
0.00
(-0.701%) ⇩
(April 17, 2026, 4 p.m.
EDT)
After hours: 0.49 +0.01 (1.744%) ⇧ (April 17, 2026, 7:46 p.m. EDT) Short-term: ★★☆☆☆ | Long-term: ★☆☆☆☆ | Dividends: ☆☆☆☆☆ |
Hot Take | April 11, 2026, 4:06 p.m. EDT
XTNT shows mixed signals for short-term trading with a downward price trend and a negative beta, suggesting it may underperform the market. However, the recent analyst activity includes both strong buy ratings and price target adjustments, indicating potential for a rebound. For long-term investment, the stock's fundamentals are weak, with a high debt-to-equity ratio and negative operating margins, making it a risky choice. There are no dividend payouts, so it's not suitable for income-focused investors. |
| Model | MAE |
|---|---|
| AutoTheta ✓ | 0.093363 |
| AutoETS | 0.117516 |
| MSTL | 0.120223 |
| AutoARIMA | 0.205967 |
Forecast horizon: 45 days | Selected: AutoTheta
| Forecast Reliability | |
|---|---|
| Score | 22% |
| H-stat | 6.93 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.000 |
| Excess Kurtosis | 1.81 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 56.36 |
| Revenue per Share | 0.96 |
| Market Cap | 67,456,872 |
| Trailing P/E | 16.05 |
| Forward P/E | -24.08 |
| Beta | -0.16 |
| Profit Margins | 3.71% |
| Website | https://xtantmedical.com |
| Attribute | Value |
|---|---|
| 52 Week Change | -0.020408154 |
| Address1 | 664 Cruiser Lane |
| All Time High | 1,080.0 |
| All Time Low | 0.33 |
| Ask | 0.5 |
| Ask Size | 200 |
| Average Analyst Rating | 1.0 - Strong Buy |
| Average Daily Volume10 Day | 224,220 |
| Average Daily Volume3 Month | 163,174 |
| Average Volume | 163,174 |
| Average Volume10Days | 224,220 |
| Beta | -0.16 |
| Bid | 0.4815 |
| Bid Size | 4,700 |
| Book Value | 0.364 |
| City | Belgrade |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 0.4816 |
| Current Ratio | 2.654 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,774,915,200 |
| Day High | 0.5006 |
| Day Low | 0.4814 |
| Debt To Equity | 56.36 |
| Display Name | Xtant Medical |
| Dividend Date | 1,518,566,400 |
| Earnings Call Timestamp End | 1,774,960,200 |
| Earnings Call Timestamp Start | 1,774,960,200 |
| Earnings Timestamp | 1,774,960,200 |
| Earnings Timestamp End | 1,778,589,000 |
| Earnings Timestamp Start | 1,778,589,000 |
| Ebitda | 12,507,000 |
| Ebitda Margins | 0.093389995 |
| Enterprise To Ebitda | 6.326 |
| Enterprise To Revenue | 0.591 |
| Enterprise Value | 79,120,872 |
| Eps Current Year | -0.05 |
| Eps Forward | -0.02 |
| Eps Trailing Twelve Months | 0.03 |
| Esg Populated | 0 |
| Exchange | ASE |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 0.5648 |
| Fifty Day Average Change | -0.08320004 |
| Fifty Day Average Change Percent | -0.14730884 |
| Fifty Two Week Change Percent | -2.0408154 |
| Fifty Two Week High | 0.95 |
| Fifty Two Week High Change | -0.4684 |
| Fifty Two Week High Change Percent | -0.49305263 |
| Fifty Two Week Low | 0.39 |
| Fifty Two Week Low Change | 0.0916 |
| Fifty Two Week Low Change Percent | 0.2348718 |
| Fifty Two Week Range | 0.39 - 0.95 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,277,991,000,000 |
| Float Shares | 54,099,965 |
| Forward Eps | -0.02 |
| Forward P E | -24.08 |
| Free Cashflow | 6,497,125 |
| Full Exchange Name | NYSE American |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.62925 |
| Gross Profits | 84,273,000 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.15175 |
| Held Percent Institutions | 0.57941 |
| Implied Shares Outstanding | 140,068,260 |
| Industry | Medical Devices |
| Industry Disp | Medical Devices |
| Industry Key | medical-devices |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Last Split Date | 1,518,566,400 |
| Last Split Factor | 1:12 |
| Long Business Summary | Xtant Medical Holdings, Inc. provides regenerative medicine products and medical devices for orthopedic and neurological surgeons in the United States and internationally. It offers OsteoSponge, a natural scaffold for cellular in-growth; OsteoSelect DBM Putty, a moldable demineralized bone matrix; OsteoSelect PLUS DBM Putty to deliver handling properties and ensure patient safety through validated and terminal sterilization; 3Demin, a family of allografts that maximizes osteoconductivity and the osteoinductive potential of human bone; OsteoFactor Pro, a processed allograft that contains retained growth factors found within the endosteum layer of allograft bone; OsteoVive Plus, an aseptically processed and viable bone allograft; and nanOss products that provide osteoconductive nano-structured hydroxyapatite and an engineered extracellular matrix bioscaffold collagen carrier. It also provides sports allografts for anterior and posterior cruciate ligament repairs, anterior cruciate ligament reconstruction, and meniscal repair; milled spinal allografts for cortical bone milled to desired shapes and dimensions; and traditional allografts for orthopedics, neurology, podiatry, oral/maxillofacial, genitourinary, and plastic/reconstructive applications. In addition, it offers cervical products comprising Spider cervical plating, Streamline OCT system, and CervAlign systems; thoracolumbar products, such as of Axle-X interspinous fusion, Streamline MIS spinal fixation, Streamline TL spinal fixation, and HPS 2.0 hybrid performance systems; Silex sacroiliac joint fusion systems; interbody products comprising Calix for cervical and thoracolumbar applications, Irix-C Cervical and Irix-A lumbar integrated dusion systems, and Fortilink implants; Contact ALP (Anterior Lumbar Plate) System; and interlaminar stabilization products, such as Coflex device for lumbar spinal stenosis; and CoFix implants for back and disc pain. The company is headquartered in Belgrade, Montana. |
| Long Name | Xtant Medical Holdings, Inc. |
| Market | us_market |
| Market Cap | 67,456,872 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_11129226 |
| Most Recent Quarter | 1,767,139,200 |
| Net Income To Common | 4,973,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 67,456,874 |
| Number Of Analyst Opinions | 2 |
| Open | 0.49 |
| Operating Cashflow | 12,546,000 |
| Operating Margins | -0.02917 |
| Payout Ratio | 0.0 |
| Peg Ratio | 1.74 |
| Phone | 406 388 0480 |
| Post Market Change | 0.008400023 |
| Post Market Change Percent | 1.7441908 |
| Post Market Price | 0.49 |
| Post Market Time | 1,776,469,576 |
| Previous Close | 0.485 |
| Price Eps Current Year | -9.632 |
| Price Hint | 4 |
| Price To Book | 1.323077 |
| Price To Sales Trailing12 Months | 0.50368387 |
| Profit Margins | 0.037130002 |
| Quick Ratio | 1.182 |
| Quote Type | EQUITY |
| Recommendation Key | strong_buy |
| Recommendation Mean | 1.0 |
| Region | US |
| Regular Market Change | -0.00340003 |
| Regular Market Change Percent | -0.701037 |
| Regular Market Day High | 0.5006 |
| Regular Market Day Low | 0.4814 |
| Regular Market Day Range | 0.4814 - 0.5006 |
| Regular Market Open | 0.49 |
| Regular Market Previous Close | 0.485 |
| Regular Market Price | 0.4816 |
| Regular Market Time | 1,776,456,000 |
| Regular Market Volume | 119,338 |
| Return On Assets | 0.04844 |
| Return On Equity | 0.105900005 |
| Revenue Growth | 0.027 |
| Revenue Per Share | 0.96 |
| Sand P52 Week Change | 0.38150132 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 140,068,260 |
| Shares Percent Shares Out | 0.00029999999 |
| Shares Short | 39,674 |
| Shares Short Previous Month Date | 1,772,150,400 |
| Shares Short Prior Month | 18,020 |
| Short Name | Xtant Medical Holdings, Inc. |
| Short Percent Of Float | 0.00059999997 |
| Short Ratio | 0.28 |
| Source Interval | 15 |
| State | MT |
| Symbol | XTNT |
| Target High Price | 1.2 |
| Target Low Price | 1.0 |
| Target Mean Price | 1.1 |
| Target Median Price | 1.1 |
| Total Cash | 17,053,000 |
| Total Cash Per Share | 0.122 |
| Total Debt | 28,717,000 |
| Total Revenue | 133,927,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | 0.03 |
| Trailing P E | 16.053333 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 0.6475 |
| Two Hundred Day Average Change | -0.16589999 |
| Two Hundred Day Average Change Percent | -0.2562162 |
| Type Disp | Equity |
| Volume | 119,338 |
| Website | https://xtantmedical.com |
| Zip | 59,714 |